These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21395528)

  • 1. Metabolomics and its practical value in pharmaceutical industry.
    Wei R
    Curr Drug Metab; 2011 May; 12(4):345-58. PubMed ID: 21395528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Untargeted Metabolomics Be Utilized in Drug Discovery/Development?
    Caldwell GW; Leo GC
    Curr Top Med Chem; 2017; 17(24):2716-2739. PubMed ID: 28685690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of metabolomics in drug discovery and development.
    Wishart DS
    Drugs R D; 2008; 9(5):307-22. PubMed ID: 18721000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential of metabolomics in preclinical and clinical drug development.
    Kumar B; Prakash A; Ruhela RK; Medhi B
    Pharmacol Rep; 2014 Dec; 66(6):956-63. PubMed ID: 25443721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics.
    Mussap M; Loddo C; Fanni C; Fanos V
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):115-134. PubMed ID: 31958027
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolomics and its potential in drug development.
    Beyoğlu D; Idle JR
    Biochem Pharmacol; 2013 Jan; 85(1):12-20. PubMed ID: 22935449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics in pharmaceutical research and development: metabolites, mechanisms and pathways.
    Xu EY; Schaefer WH; Xu Q
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):40-52. PubMed ID: 19152212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics in pharmaceutical research and development.
    Puchades-Carrasco L; Pineda-Lucena A
    Curr Opin Biotechnol; 2015 Dec; 35():73-7. PubMed ID: 25900094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capillary electrophoresis-mass spectrometry in metabolomics: the potential for driving drug discovery and development.
    Wang X; Li K; Adams E; Van Schepdael A
    Curr Drug Metab; 2013 Sep; 14(7):807-13. PubMed ID: 23937174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging applications of metabolomics in drug discovery and precision medicine.
    Wishart DS
    Nat Rev Drug Discov; 2016 Jul; 15(7):473-84. PubMed ID: 26965202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics for bioactivity assessment of natural products.
    Yuliana ND; Khatib A; Choi YH; Verpoorte R
    Phytother Res; 2011 Feb; 25(2):157-69. PubMed ID: 20658470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomics and transcriptomics in drug discovery.
    Dopazo J
    Drug Discov Today; 2014 Feb; 19(2):126-32. PubMed ID: 23773860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emergence of metabolomics as a key discipline in the drug discovery process.
    Fillet M; Frédérich M
    Drug Discov Today Technol; 2015 Jun; 13():19-24. PubMed ID: 26190679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UPLC-MS for metabolomics: a giant step forward in support of pharmaceutical research.
    Nassar AF; Wu T; Nassar SF; Wisnewski AV
    Drug Discov Today; 2017 Feb; 22(2):463-470. PubMed ID: 27919805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective.
    Wong H; Bohnert T; Damian-Iordache V; Gibson C; Hsu CP; Krishnatry AS; Liederer BM; Lin J; Lu Q; Mettetal JT; Mudra DR; Nijsen MJMA; Schroeder P; Schuck E; Suryawanshi S; Trapa P; Tsai A; Wang H; Wu F
    Drug Discov Today; 2017 Oct; 22(10):1447-1459. PubMed ID: 28476536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics in the pharmaceutical industry.
    Reily MD; Tymiak AA
    Drug Discov Today Technol; 2015 Jun; 13():25-31. PubMed ID: 26190680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular drug discovery: a perspective from a research-based pharmaceutical company.
    Gromo G; Mann J; Fitzgerald JD
    Cold Spring Harb Perspect Med; 2014 Jun; 4(6):. PubMed ID: 24890831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics in drug discovery and development.
    Robertson DG; Frevert U
    Clin Pharmacol Ther; 2013 Nov; 94(5):559-61. PubMed ID: 24145714
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.